Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Evaluation of bioavailability by different methods.

W A Ritschel, S A Hussain, B Schneider

    Methods and Findings in Experimental and Clinical Pharmacology
    |August 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    One mother for two species via obligate cross-species cloning in ants.

    Nature·2025
    Same author

    Incretin-responsive human pancreatic adipose tissue organoids: A functional model for fatty pancreas research.

    Molecular metabolism·2024
    Same author

    Urbanization without isolation: the absence of genetic structure among cities and forests in the tiny acorn ant <i>Temnothorax nylanderi</i>.

    Biology letters·2020
    Same author

    Optimizing the trade-off between spatial and genetic sampling efforts in patchy populations: towards a better assessment of functional connectivity using an individual-based sampling scheme.

    Molecular ecology·2013
    Same author

    Skin swabbing as a new efficient DNA sampling technique in amphibians, and 14 new microsatellite markers in the alpine newt (Ichthyosaura alpestris).

    Molecular ecology resources·2012
    Same author

    In vivo characterisation of a novel water-soluble Cyclosporine A prodrug for the treatment of dry eye disease.

    European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V·2011

    This study compared bioavailability evaluation methods for theophylline drug products. No significant differences were found between KINPAK, NONLIN 84, and the trapezoidal rule for calculating key pharmacokinetic parameters.

    Area of Science:

    • Pharmacokinetics and Drug Development
    • Biopharmaceutical Analysis
    • Regulatory Science

    Background:

    • Demonstrating bioavailability or bioequivalence is crucial for drug product marketing approval.
    • Bioavailability assessments typically involve statistical evaluation of Area Under the Curve (AUC), peak concentration (Cmax), and time to peak (tmax).
    • Existing methods for calculating these pharmacokinetic parameters can be subjective and operator-dependent.

    Purpose of the Study:

    • To compare the performance of two established bioavailability evaluation procedures (NONLIN 84 and linear trapezoidal rule) against a new, operator-independent method (KINPAK).
    • To assess these methods using theophylline, a drug with significant inter- and intra-individual disposition variability.
    • To evaluate the methods for both single and multiple dose administrations.

    Related Experiment Videos

    Main Methods:

    • Comparison of bioavailability parameter calculations (AUC, Cmax, tmax) using NONLIN 84, linear trapezoidal rule, and KINPAK.
    • Utilized theophylline as a model drug in single-dose (tablet vs. elixir) and multiple-dose (tablet vs. Theodur) studies.
    • KINPAK was highlighted for its ability to identify outliers in concentration-time data and its model-independent approach.

    Main Results:

    • No statistically significant differences were observed between the NONLIN 84, linear trapezoidal rule, and KINPAK methods for theophylline bioavailability parameters in both single and multiple dose studies.
    • The study suggests that while differences were not found in this specific case, this outcome is not guaranteed for all drug products.
    • KINPAK demonstrated advantages in standardized computation, outlier recognition, and automated data handling.

    Conclusions:

    • The evaluated methods for bioavailability assessment showed comparable results for theophylline under the study conditions.
    • KINPAK offers a standardized, operator-independent approach for pharmacokinetic analysis, enhancing data integrity and regulatory submission readiness.
    • Further studies are recommended to confirm these findings across a broader range of drug products and administration routes.